- Home
- SNTI vs FEBO Comparison
SNTI vs FEBO Comparison
Compare SNTI & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- FEBO
- Stock Information
- Founded
- SNTI 2016
- FEBO 1993
- Country
- SNTI United States
- FEBO Hong Kong
- Employees
- SNTI N/A
- FEBO N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- FEBO
- Sector
- SNTI Health Care
- FEBO
- Exchange
- SNTI Nasdaq
- FEBO Nasdaq
- Market Cap
- SNTI 19.1M
- FEBO 19.4M
- IPO Year
- SNTI N/A
- FEBO 2023
- Fundamental
- Price
- SNTI $4.67
- FEBO $1.57
- Analyst Decision
- SNTI Strong Buy
- FEBO
- Analyst Count
- SNTI 1
- FEBO 0
- Target Price
- SNTI $12.00
- FEBO N/A
- AVG Volume (30 Days)
- SNTI 115.8K
- FEBO 65.5K
- Earning Date
- SNTI 11-14-2024
- FEBO 10-03-2024
- Dividend Yield
- SNTI N/A
- FEBO N/A
- EPS Growth
- SNTI N/A
- FEBO N/A
- EPS
- SNTI N/A
- FEBO N/A
- Revenue
- SNTI N/A
- FEBO $16,319,897.00
- Revenue This Year
- SNTI $11.52
- FEBO N/A
- Revenue Next Year
- SNTI $78.57
- FEBO N/A
- P/E Ratio
- SNTI N/A
- FEBO N/A
- Revenue Growth
- SNTI N/A
- FEBO 9.01
- 52 Week Low
- SNTI $1.52
- FEBO $1.20
- 52 Week High
- SNTI $16.94
- FEBO $17.68
- Technical
- Relative Strength Index (RSI)
- SNTI 56.65
- FEBO 43.50
- Support Level
- SNTI $3.72
- FEBO $1.54
- Resistance Level
- SNTI $4.93
- FEBO $2.31
- Average True Range (ATR)
- SNTI 0.46
- FEBO 0.23
- MACD
- SNTI 0.01
- FEBO 0.02
- Stochastic Oscillator
- SNTI 81.82
- FEBO 14.94
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About FEBO Fenbo Holdings Limited
Fenbo Holdings Ltd is a company engaged in producing premium personal care electric appliances principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.